| Filed On | Filing |
|---|---|
| 26 Oct 2026 |
Form 4: Rider Michael J, Global General Counsel
Sold 400 shares ($102K) |
| 23 Oct 2026 | 144 |
| 08 Oct 2026 |
Form 4: Farrell Michael J., Director
Received 4,991 shares by exercise or conversion ($730K) · Sold 4,991 shares ($1.13M) |
| 07 Oct 2026 | 144 |
| 01 Oct 2026 |
Form 4/A: Farrell Michael J., Director
Holds 479,803 shares of ResMed Common Stock |
| 01 Oct 2026 |
Form 4: Leong Justin, Chief Product Officer
Received 6,461 shares as a grant or award |
| 01 Oct 2026 |
Form 4: Rider Michael J, Global General Counsel
Received 3,230 shares as a grant or award |
| 01 Oct 2026 |
Form 4: Farrell Michael J., Director
Received 13,547 shares as a grant or award |
| 01 Oct 2026 |
Form 4: Bloomer Aaron, Chief Financial Officer
Received 9,072 shares as a grant or award |
| 01 Oct 2026 |
Proxy statement: annual meeting on November 18, 2026
CEO pay $16.2M, up 10% · say-on-pay vote |
| 01 Oct 2026 | DEFA14A |
| 01 Oct 2026 | ARS |
| 10 Sep 2026 |
Form 4: Farrell Michael J., Director
Received 4,991 shares by exercise or conversion ($730K) · Sold 4,991 shares ($1.11M) |
| 08 Sep 2026 | 144 |
| 04 Sep 2026 |
Form 4: Farrell Peter C, Director
Sold 970 shares ($228K) |
| 02 Sep 2026 | 144 |
| 01 Sep 2026 | 8-K: Other Events |
| 17 Aug 2026 | 8-K: Changes in Registrant's Certifying Accountant; Departure/Election of Directors or Officers; Compensation +1 more |
| 13 Aug 2026 | 10-K |
| 11 Aug 2026 |
Form 4: Farrell Michael J., Director
Received 4,991 shares by exercise or conversion ($730K) · Sold 4,991 shares ($1.03M) |
Loading...
